Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New 3-Times-Per-Week Regimen For Teva’s Copaxone Safe, Effective & Increases Patient Compliance #ECTRIMS2015
Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.
MicroRNA 182 inhibits CD4(+)CD25(+)Foxp3(+) Treg differentiation in experimental autoimmune encephalomyelitis.
Neuromuscular Determinants For Walking Performance In Individuals With Multiple Sclerosis: 2570 Board #93 June 3, 9: 30 AM - 11: 00 AM.
YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.
Retinal imaging and axonal degeneration in later onset multiple sclerosis.
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
The Gut Microbiota in Immune-Mediated Inflammatory Diseases.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation.
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.
Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis.
Symmetry in vertical ground reaction force is not related to walking and balance difficulties in people with multiple sclerosis.
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Peripheral neuropathy in patients with myotonic dystrophy type 2.
Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.
A silent creeper-Multiple sclerosis.
Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's disease.
Complex coacervation for the development of composite edible films based on LM pectin and sodium caseinate.
Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons.
Molecular characterization of biotic and abiotic stress-responsive MAP kinase genes, IbMPK3 and IbMPK6, in sweetpotato.
Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
[Anti-NMDA Receptor Antibody-Related Encephalitis].
HLA Genetic Risk Burden in Multiple Sclerosis.
Pages
« first
‹ previous
…
794
795
796
797
798
799
800
801
802
…
next ›
last »